23.77
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt PFE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Pfizer Inc Aktie (PFE) Neueste Nachrichten
Can a multibillion-dollar deal put Pfizer in the obesity big leagues? - PharmaVoice
November 7th Options Now Available For Pfizer (PFE) - Nasdaq
Does This Acquisition Make Pfizer Stock a Great Buy? - Yahoo Finance
Pfizer to showcase cancer drug data at ESMO Congress 2025 By Investing.com - Investing.com Canada
Essex Financial Services Inc. Purchases 29,086 Shares of Pfizer Inc. $PFE - MarketBeat
Ruffer LLP Sells 792,785 Shares of Pfizer Inc. $PFE - MarketBeat
MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Decreases Stock Position in Pfizer Inc. $PFE - MarketBeat
Pfizer to showcase cancer drug data at ESMO Congress 2025 - Investing.com
Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025 - Business Wire
Pfizer Inc. $PFE Shares Purchased by Penn Davis Mcfarland Inc. - MarketBeat
Pfizer Tries to Fatten Its Profits With Weight Loss Drugs - Investing.com
Xcel Wealth Management LLC Reduces Stock Position in Pfizer Inc. $PFE - MarketBeat
Santori & Peters Inc. Purchases 11,000 Shares of Pfizer Inc. $PFE - MarketBeat
TD Private Client Wealth LLC Grows Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Sheets Smith Wealth Management Sells 27,150 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Is Buying Weight Loss Biotech Metsera. Here's Why Viking Therapeutics Shareholders May Be Cheering. - Yahoo Finance
Pfizer Agrees to Take Over Metsera for $4.9 Billion - CHEManager
Pneumococcal Vaccine Market Opportunities and Strategies to 2034 - GlobeNewswire Inc.
Dividend Stock Portfolio for Retirement: Pfizer’s (PFE) Reliable Payouts - Yahoo Finance
Pfizer boosts push for obesity treatments with $4.9B deal for Metsera - LiveNOW from FOX
Pfizer: Jefferies raises target price - MarketScreener
Foster Victor Wealth Advisors LLC Has $16.48 Million Stake in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Sold by Public Employees Retirement System of Ohio - MarketBeat
Should You Forget Pfizer and Buy These Unstoppable Stocks Instead? - AOL.com
78,922 Shares in Pfizer Inc. $PFE Bought by IMS Capital Management - MarketBeat
With 67% institutional ownership, Pfizer Inc. (NYSE:PFE) is a favorite amongst the big guns - Yahoo Finance
Jefferies Adjusts Price Target on Pfizer to $34 From $33, Maintains Buy Rating - MarketScreener
Arvinas stock downgraded by BofA as Pfizer partnership shifts - Investing.com
Wilsey Asset Management Inc. Has $23.88 Million Stake in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Sold by Fifth Third Bancorp - MarketBeat
Pfizer to buy obesity drug maker Metsera - Medical Dialogues
Pfizer Inc is Wall Street Wrong to Give Up on This Comeback Story? - Yahoo Finance
17,033 Shares in Pfizer Inc. $PFE Acquired by Revisor Wealth Management LLC - MarketBeat
Autozone, Pfizer, Valley National Bancorp - TradingView
Where Will Pfizer Be in 5 Years? - Nasdaq
PFIZER INC : Receives a Buy rating from Jefferies - MarketScreener
Pfizer bets on weight-loss drugs - Global Cosmetics News
Pfizer Invites Public to View and Listen to Webcast of November 4 Conference Call with Analysts - BioSpace
Pfizer Challenges Novo Nordisk and Eli Lilly with $7.3B Metsera Buyout - NAI500
How Pfizer Inc. (PFE) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Pfizer Raises EPS Guidance and Expands Cost-Cutting Plan While Boosting Dividend Appeal - Yahoo Finance
Pfizer Inc. (PFE) Targets $4.5B in Cost Savings to Fuel R&D and Innovative Therapies - Yahoo Finance
Time to Buy Pfizer (PFE) or Metsera (MTSR) Stock? - Yahoo Finance
Pfizer’s Acquisition Of Metsera Bucks The Recent Trend For Obesity Deals - insights.citeline.com
Wachtell, Paul Weiss guide Pfizer’s $7.3bn buy of weight loss drugmaker Metsera - The Global Legal Post
Pfizer’s $5B Bet on Metsera ($MTSR) vs Viking Therapeutics ($VKTX) - MSN
Metsera (MTSR) Soars to All-Time High on $7.3-Billion Merger With Pfizer - MSN
Pfizer's $7.3B Gamble: Chasing Ozempic Rivals After Own Weight-Loss Pill Flopped - Yahoo Finance
Pfizer (PFE): Is This Healthcare Giant’s Valuation Now Too Low to Ignore? - simplywall.st
What's Pfizer Getting in Its $7.3 Billion Metsera Buyout? - sharewise.com
Metsera Stock Surges 59% Pre-Market After Pfizer Confirms Acquisition – Here Are The Details - Stocktwits
Pfizer’s Metsera buy raises competitive heat for Novo Nordisk - Proactive financial news
Pfizer stock gains as Bernstein reiterates Market Perform rating - Investing.com
Pfizer's M&A gorging can stay within its diet - Reuters
Compagnie Lombard Odier SCmA Acquires 23,382 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Sold by QSM Asset Management Ltd - MarketBeat
Eaton Financial Holdings Company LLC Acquires New Position in Pfizer Inc. $PFE - MarketBeat
Kwmg LLC Has $4.80 Million Position in Pfizer Inc. $PFE - MarketBeat
Pfizer’s future lead obesity candidate from Metsera needs to match Zepbound - Endpoints News
Caspofungin Market Size to Reach US$ 889.2 Mn by 2032, Reports Coherent Market Insights | Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd - industrytoday.co.uk
CHICAGO TRUST Co NA Buys 17,250 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Sold by Farmers Trust Co. - MarketBeat
This Hated Stock Suddenly Looks Like an Obesity Bargain - The Wall Street Journal
Park Avenue Securities LLC Invests $3.81 Million in Pfizer Inc. $PFE - MarketBeat
Grant Private Wealth Management Inc Makes New $2.98 Million Investment in Pfizer Inc. $PFE - MarketBeat
Sovran Advisors LLC Trims Holdings in Pfizer Inc. $PFE - MarketBeat
UMB Bank n.a. Sells 15,516 Shares of Pfizer Inc. $PFE - MarketBeat
Kingstone Capital Partners Texas LLC Takes $30.34 Million Position in Pfizer Inc. $PFE - MarketBeat
Viking Therapeutics Stock Gets Boost From Pfizer-Metsera Deal, Says BTIG — Retail Slams Rivals For Buying ‘Inferior Pipelines’ - Stocktwits
Pfizer : Analyst and Investor Call to Discuss Proposed Acquisition of Metsera Transcript - MarketScreener
Pfizer Inc. (PFE) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Pfizer Jumps Back Into Obesity With $4.9bn Bid For Metsera - insights.citeline.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):